Third Question of the Day November 25, 2014 One of the compounding industry's argument against the FDA having any authority over compounding pharmacies is that it should be left to the states to decide how to regulate this area, but in a list of things that IACP wants fixed

they say, "Clear distinction that any proposed Memorandum of Understanding between the FDA and the states must focus on communication about issues related to compounded preparations and not the fulfillment of prescription dispensing nor arbitrary limits on quantities."   Isn't this totally contrary to what IACP has consistently said especially if a state wants the MOU to cover these topics and areas?  The state doesn't have to enter into the MOU if it doesn't wanted to do so.  So what the compounding industry is really asking is that Congress to dictate to the states what any MOU's with the FDA can state?